In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line
Biotechnology and Bioengineering · 2023-05 · 120 (5) · 1241-1253
DOI: 10.1002/bit.28333 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 22.01.2023. Verfasst von Ho-Joon Lee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Liver Cirrhosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Institute of Toxicology, Korea Research Institute of Bioscience and Biotechnology, National Research Foundation of Korea.
Abstract (Originalsprache)
Hepatic stellate cells (HSCs) play an important role in liver fibrosis; however, owing to the heterogeneity and limited supply of primary HSCs, the development of in vitro liver fibrosis models has been impeded. In this study, we established and characterized a novel human HSC line (LSC‐1), and applied it to various types of three‐dimensional (3D) co‐culture systems with differentiated HepaRG cells. Furthermore, we compared LSC‐1 with a commercially available HSC line on conventional monolayer culture. LSC‐1 exhibited an overall upregulation of the expression of fibrogenic genes along with increased levels of matrix and adhesion proteins, suggesting a myofibroblast‐like or transdifferentiated state. However, activated states reverted to a quiescent‐like phenotype when cultured in different 3D culture formats with a relatively soft microenvironment. Additionally, LSC‐1 exerted an overall positive effect on co‐cultured differentiated HepaRG, which significantly increased hepatic functionality upon long‐term cultivation compared with that achieved with other HSC line. In 3D spheroid culture, LSC‐1 exhibited enhanced responsiveness to transforming growth factor beta 1 exposure that is caused by a different matrix‐related protein expression mechanism. Therefore, the LSC‐1 line developed in this study provides a reliable candidate model that can be used to address unmet needs, such as development of antifibrotic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
- Department of Functional Genomics, Korea University of Science & Technology (UST), Daejeon, Republic of Korea.
- General and Applied Toxicology Research Center, Korea Institute of Toxicology (KIT), Daejeon, Republic of Korea.
ORCID-Profile: Ho-Joon Lee, Kyung-Sook Chung
Förderung
- Korea Institute of Toxicology
- Korea Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea
Zitieren
APA
Lee, H. J., Mun, S. J., Jung, C. R., Kang, H. M., Kwon, J. E., Ryu, J. S., Ahn, H. S., Kwon, O. S., Ahn, J., Moon, K. S., Son, M. J., & Chung, K. S. (2023). In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line. Biotechnology and Bioengineering, 120(5), 1241-1253. https://doi.org/10.1002/bit.28333
Vancouver
Lee HJ, Mun SJ, Jung CR, Kang HM, Kwon JE, Ryu JS, et al. In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line. Biotechnology and Bioengineering. 2023;120(5):1241-1253. doi:10.1002/bit.28333
BibTeX
@article{Lee2023,
author = {Lee, Ho-Joon and Mun, Seon Ju and Jung, Cho-Rok and Kang, Hyun-Mi and Kwon, Jae-Eun and Ryu, Jae-Sung and Ahn, Hyo-Suk and Kwon, Ok-Seon and Ahn, Jiwon and Moon, Kyung-Sik and Son, Myung Jin and Chung, Kyung-Sook},
title = {In vitro modeling of liver fibrosis with 3D co‐culture system using a novel human hepatic stellate cell line},
journal = {Biotechnology and Bioengineering},
year = {2023},
volume = {120},
number = {5},
pages = {1241--1253},
doi = {10.1002/bit.28333}
}
EUVIMED